Ibarra-Hernández, Armando <br/><br/>
[Response to treatment with tyrosine kinase inhibitors in chronic myeloid leukemia].  [electronic resource] 

 -  Revista medica del Instituto Mexicano del Seguro Social   
 - 266-9 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>2448-5667 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Benzamides--therapeutic use<br/>Cross-Sectional Studies<br/>Dasatinib<br/>Female<br/>Humans<br/>Imatinib Mesylate<br/>Leukemia, Myelogenous, Chronic, BCR-ABL Positive--drug therapy<br/>Male<br/>Piperazines--therapeutic use<br/>Protein Kinase Inhibitors--therapeutic use<br/>Pyrimidines--therapeutic use<br/>Thiazoles--therapeutic use<br/>Treatment Outcome